Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Therapeutic Strategies for the Secondary Prevention of Ischemic Stroke and Transient Ischemic Attack

Program Overview

This CME activity is derived from content presented at the 7th Annual European Stroke Organization Conference (ESOC) 2021 Virtual. The expert faculty, led by Dr. Stephan Mayer, will first provide an overview of double antiplatelet therapy, including pathobiology, disease mechanisms and platelet activation. Following, clinical trial data in stroke and cardiovascular disease will be reviewed. Next, the pros ...
View Course
Current Strategies, Diagnostic Approaches, and Advanced Therapeutics for the Treatment of Patients with Interstitial Lung Disease

Program Overview

This CME/CE symposium is derived from content presented at the Congress of Clinical Rheumatology East Meeting and will highlight recent advances in the treatment and management of patients with interstitial lung disease (ILD). The expert faculty, Drs. Dinesh Khanna and Kevin Flaherty, will first review best practices for screening and diagnosing patients. Following, recent clinical trial data of ...
View Course

Program Overview

In this module, Jamie Faber, PA-C, along with Scott Kopetz, MD, PhD, course chair, will first delve into the practical considerations of biomarker testing for the interprofessional team. The expert faculty will also provide an overview of ctDNA, including the clinical implications in the colorectal cancer landscape. Following, best practices for managing adverse events to improve patient outcomes ...
View Course
Post Conference Review and Analysis of mCRC Data from ESMO GI 2021

Program Overview

In this module, Michael Sangmin Lee, MD, along with Scott Kopetz, MD, PhD, course chair, will review data presented at the ESMO World Congress on Gastrointestinal Cancer 2021 Meeting. The faculty will outline a few key studies from the meeting, focusing on populations such as those who were previously untreated and patients who received prior bevacizumab treatment. Current ...
View Course
Post Conference Review and Analysis of mCRC Data from ASCO 2021

Program Overview

In this module, Michael Overman, MD, along with Scott Kopetz, MD, PhD, course chair, will highlight information presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. The faculty will first analyze data regarding frontline metastatic colorectal cancer (mCRC), including the Keynote 177 and FOCUS 4N studies. Following, updates for both second-line mCRC and refractory mCRC ...
View Course
Review of Targeted Therapeutic Options for BRAF-Mutated Metastatic Colorectal Cancer, Including Combination Therapies

Program Overview

In this module, Benny Johnson, DO, along with Scott Kopetz, MD, PhD, course chair, will analyze targeted therapeutic options for BRAF-mutated metastatic colorectal cancer, with a focus on combination therapies. The faculty will highlight the pathway to precision therapy for BRAFV600E mutant metastatic colorectal cancer (mCRC), debating the clinical implications of recent trial data in an interactive panel ...
View Course

Upcoming Events

2021 ASHP Midyear Clinical Meeting and Exhibition

December 5th – 9th, 2021

The Alliance 2022 Annual Conference

January 12th – 15th, 2022

Maui Derm for Dermatologists 2022

January 24th – 28th, 2022

Advanced Curriculum for Multiple Sclerosis 2022

February 22nd, 2022